Longevity Escape Velocity

Rewriting theEpoch of Aging.

EpochRevive engineers partial epigenetic reprogramming to reset the biological clock — without erasing what makes you, you. Science at the frontier of human longevity.

Up to 0%

Epigenetic age reversal in preclinical models

0x

Faster cellular reprogramming vs previous methods

0+

Research collaborations across 4 continents

0

Target year for Phase I clinical trials

See the rapid global progress
Our Mission

Aging isn't fate. It's a program.

For billions of years, life has been shackled by entropy. We believe epigenetic reprogramming is the key to unlocking the biological reset mechanism — safely, selectively, at scale.

EpochRevive isn't about living forever. It's about living fully — with the vitality of youth preserved alongside the wisdom of experience. We call this longevity escape velocity: the point at which science extends healthy lifespan faster than time can take it.

Read our full purpose statement

“We are not building a pill. We are building a reset button for the biological program that governs decay.”

— EpochRevive Founding Vision
Core Technology

The Science of Biological Reset

Three pillars of innovation converging to make epigenetic rejuvenation safe, targeted, and clinically viable.

Partial Reprogramming

Using modified Yamanaka factor cocktails (OSK without MYC), we transiently express pluripotency genes to reset methylation patterns — stopping before full dedifferentiation.

Safety-First Architecture

Our controlled pulse delivery system ensures reprogramming occurs within safe thresholds. Multi-layered kill switches prevent runaway expression in any tissue type.

Epigenetic Clock Validation

We measure true biological age reversal using Horvath, GrimAge, and PhenoAge clocks. Our preclinical models show up to 47% methylation age reduction with maintained cell identity.

Join the Research

We're assembling world-class scientists, bioinformaticians, and computational biologists. If you're driven by the hardest questions in aging biology — we're building your lab.

Explore Opportunities

Partner With Us

The longevity market is projected at $600B by 2025. EpochRevive is positioned at the convergence of the most powerful biotech wave in human history. Review our vision and traction.

Investor Relations

The epoch of aging ends here.

Join a growing community of scientists, thinkers, and investors who believe the greatest problem we can solve is time itself.